Puma Stock Hits 52-Week High as Investors Bet on Turnaround

Puma shares surge 62% from lows, defying grim 2026 forecasts of sales decline and operating loss. Investor focus turns to Q1 results and AGM as short interest spikes.

Puma SE shares surged to a 52-week high of EUR 25.11, a remarkable gain of roughly 62% from their November low. This rally is unfolding even as the company navigates what it officially terms a "transition year," highlighting a stark divergence between current market sentiment and the firm's challenging financial fundamentals.

The backdrop for this surge is undeniably difficult. For the full 2026 fiscal year, Puma anticipates a currency-adjusted sales decline in the low to mid-single-digit percentage range. Its operating result is forecast to land between a loss of EUR 50 million and EUR 150 million, a range that includes one-off effects from an ongoing cost-efficiency program. These projections follow a deeply troubled 2025, where the sportswear giant reported a net loss of approximately EUR 644 million on revenue that fell 8.1% to EUR 7.3 billion. The prior year's operating profit of EUR 549 million swung to an EBIT loss of EUR 357 million, leading the board to scrap its dividend.

Investor focus now shifts to two imminent events that will test the rally's durability. The company is scheduled to release its first-quarter 2026 results on April 30, followed by its Annual General Meeting in Herzogenaurach on May 19. CEO Arthur Hoeld has already warned of another operating loss for 2026, with a sustainable return to growth not expected before 2027.

Amid the financial strain, Puma is pursuing strategic initiatives and grappling with external pressures. A significant headwind comes from U.S. trade policy, where tariffs imposed in February 2025 are estimated to have negatively impacted pre-tax profit by about EUR 80 million. In response, a Puma subsidiary has filed a lawsuit in the U.S. Court of International Trade in New York, challenging the duties as unlawful. While a U.S. customs refund portal is slated to launch by the end of April, analysts caution against factoring potential repayments into financial models due to the process's complexity.

On a more positive note, operational adjustments are showing early promise. The reduction of excess inventory is progressing faster than planned, with management targeting a normalized stock level by the end of 2026. This is a critical step to avoid the margin-crushing discounting that plagued the company when warehouses were overfull.

Strategically, Puma is doubling down on Asia. The company has signed an agreement with Chinese firm Shincell New Materials to co-develop the next generation of its NITRO™ running shoe foam technology. A dedicated laboratory is being established in Suzhou to spearhead this research, with the first products expected in upcoming seasons. This move aligns with the significant 29% stake held in Puma by Anta Sports Products.

The market remains deeply divided on Puma's prospects. Short interest has more than doubled to 8.08%, significantly above its twelve-month average of 3.41%. This elevated level of skepticism creates a volatile setup: disappointing Q1 figures could trigger further selling pressure, while a positive earnings surprise could force short sellers to cover their positions, potentially accelerating the stock's ascent. The coming weeks will reveal whether the current price strength is a prelude to recovery or a rally built on premature optimism.